|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Patton SE, Hall MC and Ozen H: Bladder
cancer. Curr Opin Oncol. 14:265–272. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Amling CL: Diagnosis and management of
superficial bladder cancer. Curr Probl Cancer. 25:219–278. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Picard V, Bergeron A, Larue H and Fradet
Y: MAGE-A9 mRNA and protein expression in bladder cancer. Int J
Cancer. 120:2170–2177. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mitropoulos D, Kiroudi-Voulgari A,
Nikolopoulos P, Manousakas T and Zervas A: Accuracy of cystoscopy
in predicting histologic features of bladder lesions. J Endourol.
19:861–864. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Karakiewicz PI, Benayoun S, Zippe C,
Lüdecke G, Boman H, Sanchez-Carbayo M, Casella R, Mian C, Friedrich
MG, Eissa S, et al: Institutional variability in the accuracy of
urinary cytology for predicting recurrence of transitional cell
carcinoma of the bladder. BJU Int. 97:997–1001. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kanojia D, Garg M, Saini S, Agarwal S,
Parashar D, Jagadish N, Seth A, Bhatnagar A, Gupta A, Kumar R, et
al: Sperm associated antigen 9 plays an important role in bladder
transitional cell carcinoma. PLoS One. 8:e813482013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dyrskjot L, Zieger K, Lildal T Kissow,
Reinert T, Gruselle O, Coche T, Borre M and Ørntoft TF: Expression
of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma. Br
J Cancer. 107:116–122. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Agarwal S, Saini S, Parashar D, Verma A,
Sinha A, Jagadish N, Batra A, Suri S, Gupta A, Ansari AS, et al:
The novel cancer-testis antigen A-kinase anchor protein 4 (AKAP4)
is a potential target for immunotherapy of ovarian serous
carcinoma. Oncoimmunology. 2:e242702013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Simpson AJ, Caballero OL, Jungbluth A,
Chen YT and Old LJ: Cancer/testis antigens, gametogenesis and
cancer. Nat Rev Cancer. 5:615–625. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zendman AJ, Ruiter DJ and Van Muijen GN:
Cancer/testis-associated genes: Identification, expression profile
and putative function. J Cell Physiol. 194:272–288. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Scanlan MJ, Gure AO, Jungbluth AA, Old LJ
and Chen YT: Cancer/testis antigens: An expanding family of targets
for cancer immunotherapy. Immunol Rev. 188:22–32. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Scanlan MJ, Simpson AJ and Old LJ: The
cancer/testis genes: Review, standardization, and commentary.
Cancer Immun. 4:12004.PubMed/NCBI
|
|
14
|
Suri A, Saini S, Sinha A, Agarwal S, Verma
A, Parashar D, Singh S, Gupta N and Jagadish N: Cancer testis
antigens: A new paradigm for cancer therapy. Oncoimmunology.
1:1194–1196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ghafouri-Fard S and Modarressi MH:
Cancer-testis antigens: Potential targets for cancer immunotherapy.
Arch Iran Med. 12:395–404. 2009.PubMed/NCBI
|
|
16
|
Chen YT, Iseli C, Venditti CA, Old LJ,
Simpson AJ and Jongeneel CV: Identification of a new cancer/testis
gene family, CT47, among expressed multicopy genes on the human X
chromosome. Genes Chromosomes Cancer. 45:392–400. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Caballero OL and Chen YT: Cancer/testis
(CT) antigens: Potential targets for immunotherapy. Cancer Sci.
100:2014–2021. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yin B, Liu G, Wang XS, Zhang H, Song YS
and Wu B: Expression profile of cancer-testis genes in transitional
cell carcinoma of the bladder. Urol Oncol. 30:886–892. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Patard JJ, Brasseur F, Gil-Diez S,
Radvanyi F, Marchand M, François P, Abi-Aad A, Van Cangh P, Abbou
CC, Chopin D, et al: Expression of MAGE genes in transitional-cell
carcinomas of the urinary bladder. Int J Cancer. 64:60–64. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nishiyama T, Tachibana M, Horiguchi Y,
Nakamura K, Ikeda Y, Takesako K and Murai M: Immunotherapy of
bladder cancer using autologous dendritic cells pulsed with human
lymphocyte antigen-A24-specific MAGE-3 peptide. Clin Cancer Res.
7:23–31. 2001.PubMed/NCBI
|
|
21
|
Sharma P, Gnjatic S, Jungbluth AA,
Williamson B, Herr H, Stockert E, Dalbagni G, Donat SM, Reuter VE,
Santiago D, et al: Frequency of NY-ESO-1 and LAGE-1 expression in
bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a
patient with bladder cancer. Cancer Immun. 3:192003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sharma P, Shen Y, Wen S, Bajorin DF,
Reuter VE, Old LJ and Jungbluth AA: Cancer-testis antigens:
Expression and correlation with survival in human urothelial
carcinoma. Clin Cancer Res. 12:5442–5447. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kurashige T, Noguchi Y, Saika T, Ono T,
Nagata Y, Jungbluth A, Ritter G, Chen YT, Stockert E, Tsushima T,
et al: Ny-ESO-1 expression and immunogenicity associated with
transitional cell carcinoma: Correlation with tumor grade. Cancer
Res. 61:4671–4674. 2001.PubMed/NCBI
|
|
24
|
Montironi R and Lopez-Beltran A: The 2004
WHO Classification of bladder tumors: A summary and commentary. Int
J Surg Pathol. 13:143–153. 2004. View Article : Google Scholar
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Eddy EM: Male germ cell gene expression.
Recent Prog Horm Res. 57:103–128. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Reuter VE: Pathology of bladder cancer:
Assessment of prognostic variables and response to therapy. Semin
Oncol. 17:524–532. 1990.PubMed/NCBI
|
|
28
|
Bane BL, Rao JY and Hemstreet GP:
Pathology and staging of bladder cancer. Semin Oncol. 23:546–570.
1996.PubMed/NCBI
|
|
29
|
Epstein JI, Amin MB, Reuter VR and Mostofi
FK: The world health organization/international society of
urological pathology consensus classification of urothelial
(transitional cell) neoplasms of the urinary bladder. Bladder
consensus conference committee. Am J Surg Pathol. 22:1435–1448.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Spruck CH III, Ohneseit PF,
Gonzalez-Zulueta M, Esrig D, Miyao N, Tsai YC, Lerner SP, Schmütte
C, Yang AS, Cote R, et al: Two molecular pathways to transitional
cell carcinoma of the bladder. Cancer Res. 54:784–788.
1994.PubMed/NCBI
|
|
31
|
Wei J, Li SJ, Shi H, Wang HY, Rong CT, Zhu
P, Jin SH, Liu J and Li JY: Characterisation of Lyzls in mice and
antibacterial properties of human LYZL6. Asian J Androl.
15:824–830. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang K, Gao R, Zhang H, Cai X, Shen C, Wu
C, Zhao S and Yu L: Molecular cloning and characterization of three
novel lysozyme-like genes, predominantly expressed in the male
reproductive system of humans, belonging to the c-type
lysozyme/alpha-lactalbumin family. Biol Reprod. 73:1064–1071. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mandal A, Klotz KL, Shetty J, Jayes FL,
Wolkowicz MJ, Bolling LC, Coonrod SA, Black MB, Diekman AB,
Haystead TA, et al: SLLP1, a unique, intra-acrosomal,
non-bacteriolytic, c lysozyme-like protein of human spermatozoa.
Biol Reprod. 68:1525–1537. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun R, Shen R, Li J, Xu G, Chi J, Li L,
Ren J, Wang Z and Fei J: Lyzl4, a novel mouse sperm-related
protein, is involved in fertilization. Acta Biochim Biophys Sin
(Shanghai). 43:346–353. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Herrero MB, Mandal A, Digilio LC, Coonrod
SA, Maier B and Herr JC: Mouse SLLP1, a sperm lysozyme-like protein
involved in sperm-egg binding and fertilization. Dev Biol.
284:126–142. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang Z, Zhang Y, Mandal A, Zhang J, Giles
FJ, Herr JC and Lim SH: The spermatozoa protein, SLLP1, is a novel
cancer-testis antigen in hematologic malignancies. Clin Cancer Res.
10:6544–6550. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Korfanty J, Toma A, Wojtas A, Rusin A,
Vydra N and Widlak W: Identification of a new mouse sperm
acrosome-associated protein. Reproduction. 143:749–757. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Grootegoed JA, Siep M and Baarends WM:
Molecular and cellular mechanisms in spermatogenesis. Baillieres
Best Pract Res Clin Endocrinol Metab. 14:331–343. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Meuwissen RL, Offenberg HH, Dietrich AJ,
Riesewijk A, van Iersel M and Heyting C: A coiled-coil related
protein specific for synapsed regions of meiotic prophase
chromosomes. Embo J. 11:5091–5100. 1992.PubMed/NCBI
|
|
40
|
Kong M, Richardson RT, Widgren EE and
O'Rand MG: Sequence and localization of the mouse sperm
autoantigenic protein, Sp17. Biol Reprod. 53:579–590. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Satie AP, Rajpert-De Meyts E, Spagnoli GC,
Henno S, Olivo L, Jacobsen GK, Rioux-Leclercq N, Jégou B and Samson
M: The cancer-testis gene, NY-ESO-1, is expressed in normal fetal
and adult testes and in spermatocytic seminomas and testicular
carcinoma in situ. Lab Invest. 82:775–780. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Mistry BV, Zhao Y, Chang TC, Yasue H,
Chiba M, Oatley J, Diaz F and Liu WS: Differential expression of
PRAMEL1, a cancer/testis antigen, during spermatogenesis in the
mouse. PLoS One. 8:e606112013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mengus C, Schultz-Thater E, Coulot J,
Kastelan Z, Goluza E, Coric M, Spagnoli GC and Hudolin T: MAGE-A10
cancer/testis antigen is highly expressed in high-grade
non-muscle-invasive bladder carcinomas. Int J Cancer.
132:2459–2463. 2013. View Article : Google Scholar : PubMed/NCBI
|
